These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29380758)

  • 1. Clinical signs in cornea and ocular surface.
    Cosar CB; Sridhar MS
    Indian J Ophthalmol; 2018 Feb; 66(2):202-206. PubMed ID: 29380758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of corneal topography and tomography: a review.
    Fan R; Chan TC; Prakash G; Jhanji V
    Clin Exp Ophthalmol; 2018 Mar; 46(2):133-146. PubMed ID: 29266624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the efficacy of fluorescein, rose bengal, lissamine green, and a new dye mixture for ocular surface staining.
    Korb DR; Herman JP; Finnemore VM; Exford JM; Blackie CA
    Eye Contact Lens; 2008 Jan; 34(1):61-4. PubMed ID: 18180687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cornea and anterior eye assessment with slit lamp biomicroscopy, specular microscopy, confocal microscopy, and ultrasound biomicroscopy.
    Martin R
    Indian J Ophthalmol; 2018 Feb; 66(2):195-201. PubMed ID: 29380757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between Tear Osmolarity and Other Ocular Surface Parameters in Primary Sjögren's Syndrome.
    Kim M; Kim HS; Na KS
    Korean J Ophthalmol; 2017 Feb; 31(1):25-31. PubMed ID: 28243020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congo red vital staining of cornea and conjunctiva.
    Norn MS
    Acta Ophthalmol (Copenh); 1976 Oct; 54(5):601-10. PubMed ID: 62486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic changes of tear fluid after cosmetic transcutaneous lower blepharoplasty measured by optical coherence tomography.
    Shao C; Fu Y; Lu L; Chen J; Shen Q; Zhu H; Fan X
    Am J Ophthalmol; 2014 Jul; 158(1):55-63.e1. PubMed ID: 24709809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular surface involvement in patients with neurofibromatosis type 1 syndrome.
    Moramarco A; Sacchetti M; Franzone F; Segatto M; Cecchetti D; Miraglia E; Roberti V; Iacovino C; Giustini S
    Graefes Arch Clin Exp Ophthalmol; 2020 Aug; 258(8):1757-1762. PubMed ID: 32388624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneal assessment technologies: current status.
    Rio-Cristobal A; Martin R
    Surv Ophthalmol; 2014; 59(6):599-614. PubMed ID: 25223496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular cystinosis: Rarity redefined.
    Naik MP; Sethi HS; Dabas S
    Indian J Ophthalmol; 2019 Jul; 67(7):1158-1159. PubMed ID: 31238435
    [No Abstract]   [Full Text] [Related]  

  • 11. Anterior Segment Optical Coherence Tomography (AS-OCT) in the Management of Dry Eye.
    Gumus K; Pflugfelder SC
    Int Ophthalmol Clin; 2017; 57(2):13-22. PubMed ID: 28282311
    [No Abstract]   [Full Text] [Related]  

  • 12. Tear film and ocular surface dysfunction in diabetes mellitus in an Indian population.
    Kesarwani D; Rizvi SWA; Khan AA; Amitava AK; Vasenwala SM; Siddiqui Z
    Indian J Ophthalmol; 2017 Apr; 65(4):301-304. PubMed ID: 28513494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Special Diagnostics of the Cornea].
    Finis D; Ackermann P; Schrader S; Geerling G
    Klin Monbl Augenheilkd; 2015 Nov; 232(11):1319-32; quiz 1333-4. PubMed ID: 26575537
    [No Abstract]   [Full Text] [Related]  

  • 14. Could corneal densitometry be used as a diagnostic and screening tool for ocular involvement in patients with gout?
    Kosekahya P; Atilgan KG; Atilgan CU; Tekin K; Koc M; Caglayan M; Ayli D; Yilmazbas P
    Int Ophthalmol; 2019 May; 39(5):991-1001. PubMed ID: 29564807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of double vital staining with 1% fluorescein and 1% lissamine green in patients with dry eye syndrome.
    Yoon KC; Im SK; Kim HG; You IC
    Cornea; 2011 Sep; 30(9):972-6. PubMed ID: 21705877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
    Sheppard JD; Torkildsen GL; Lonsdale JD; D'Ambrosio FA; McLaurin EB; Eiferman RA; Kennedy KS; Semba CP;
    Ophthalmology; 2014 Feb; 121(2):475-83. PubMed ID: 24289915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance in specular reflection and slit-imaging corneal topography.
    Braaf B; Dubbelman M; van der Heijde RG; Sicam VA
    Optom Vis Sci; 2009 May; 86(5):467-75. PubMed ID: 19342978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular argyrosis: A case with silver deposits in cornea and lens.
    Dudeja L; Dudeja I; Janakiraman A; Babu M
    Indian J Ophthalmol; 2019 Feb; 67(2):267-268. PubMed ID: 30672485
    [No Abstract]   [Full Text] [Related]  

  • 19. [New diagnostic methods for imaging the anterior segment of the eye to enable treatment modalities selection].
    Maeda N
    Nippon Ganka Gakkai Zasshi; 2011 Mar; 115(3):297-322; discussion 323. PubMed ID: 21476312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vital staining properties of neutral red. Vital staining of cornea and conjunctiva.
    Marner K; Norn MS
    Acta Ophthalmol (Copenh); 1978 Oct; 56(5):742-50. PubMed ID: 80913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.